Genetic polymorphisms in PNPLA3, TM6SF2, GCKR, and MBOAT7, may also contribute to the occurrence of NAFLD in non-obese [24–26]. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.